Status:
COMPLETED
Platelet Inhibition and Bleeding in Patients Undergoing Emergent Cardiac Surgery
Lead Sponsor:
Medical University of Graz
Conditions:
Bleeding
Eligibility:
All Genders
30-80 years
Brief Summary
The aim of the study is to evaluate if there is an association between platelet inhibition and surgery-related bleeding in patients undergoing emergent cardiac surgery during dual antiplatelet therapy...
Detailed Description
Blood for measuring platelet function is drawn before induction of anesthesia
Eligibility Criteria
Inclusion
- First time on-pump CABG with or without valve replacement
Exclusion
- Redo surgery,
- Renal insufficiency needing dialysis,
- Concomitant medication with warfarin,
- Preoperative fibrinogen \< 150 mg%
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT01468597
Start Date
January 1 2011
End Date
August 1 2014
Last Update
June 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Intensive Care Medicine, Department of Surgery, Medical University of Graz
Graz, Austria, 8036